Stable economics and growing healthcare concerns make Brazil one of the top emerging markets, with a current growth rate >20%
Marcelo Sicoli, EnterBrazil
Advertisement
Articles by Marcelo Sicoli, EnterBrazil
Advertisement
Latest Updated Articles
- Entering the Brazilian Pharmaceutical Market
Published: February 22nd 2009 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Mark Cuban Confirms Cost Plus Drugs Partnership
2
Why Rising Complexity and R&D Costs Are Fueling Specialty Drug Spending
3
Pharma Pulse: MJH Life Sciences Expands into Health Systems, Novo Nordisk Board Shakeup Moves Markets, and Mark Cuban Grows Cost Plus Drugs Network
4
BioNTech Launches Public Exchange Offer for CureVac in $1.25B All-Stock Deal
5
